Medicare Enrolled

Dr. Byung Ban, D.O.

Rheumatology · Lawrenceville, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
989 LAWRENCEVILLE HWY, Lawrenceville, GA 30046
7709621616
In practice since 2016 (10 years)
NPI: 1437512134 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ban from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ban? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ban

Dr. Byung Ban is a rheumatology specialist in Lawrenceville, GA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Ban performed 345 Medicare services across 205 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ban received a total of $14,522 from 35 pharmaceutical and/or device companies across 761 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ban is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ 345 Medicare services $14,522 industry payments

Medicare Practice Summary

Medicare Utilization ↗
345
Medicare services
Bottom 19% in GA for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
205
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
180 $91 $270
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
56 $116 $415
Complete ultrasound scan of joint
An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures.
50 $41 $185
X-ray of hand, 2 views
An X-ray imaging test of the hand using two different angles to visualize the bones and joints.
29 $24 $65
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
15 $51 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $65 $184
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,522
Total received (2021-2024)
Avg $3,631/year across 4 years
Top 24% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
761
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,522 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,357
2023
$4,943
2022
$4,194
2021
$1,028

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,151
Amgen Inc.
$577
Mallinckrodt Hospital Products Inc.
$454
Novartis Pharmaceuticals Corporation
$436
Janssen Biotech, Inc.
$427
UCB, Inc.
$266
GlaxoSmithKline, LLC.
$241
E.R. Squibb & Sons, L.L.C.
$193
PFIZER INC.
$188
GENZYME CORPORATION
$62
ANI Pharmaceuticals, Inc.
$55
SOBI, INC
$53
Sandoz Inc.
$48
Octapharma USA, Inc.
$40
SCILEX PHARMACEUTICALS INC.
$33
AstraZeneca Pharmaceuticals LP
$32
Eisai Inc.
$26
Radius Health, Inc.
$21
Aurinia Pharma U.S., Inc.
$20
Teva Pharmaceuticals USA, Inc.
$17
Actelion Pharmaceuticals US, Inc.
$16
Top 3 companies account for 50.1% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$2,547
Amgen Inc.
$1,837
AbbVie Inc.
$1,727
UCB, Inc.
$1,449
Novartis Pharmaceuticals Corporation
$1,285
Janssen Biotech, Inc.
$1,126
Mallinckrodt Hospital Products Inc.
$513
PFIZER INC.
$510
GlaxoSmithKline, LLC.
$470
Boehringer Ingelheim Pharmaceuticals, Inc.
$442
AstraZeneca Pharmaceuticals LP
$361
Aurinia Pharma U.S., Inc.
$336
Horizon Therapeutics plc
$327
Lilly USA, LLC
$300
ANI Pharmaceuticals, Inc.
$199
E.R. Squibb & Sons, L.L.C.
$193
GENZYME CORPORATION
$173
Octapharma USA, Inc.
$150
Exeltis, USA Inc.
$83
Sandoz Inc.
$71
SOBI, INC
$53
Organon LLC
$53
Alexion Pharmaceuticals, Inc.
$44
Actelion Pharmaceuticals US, Inc.
$36
SCILEX PHARMACEUTICALS INC.
$33
Genentech USA, Inc.
$31
Eisai Inc.
$26
BOSTON SCIENTIFIC CORPORATION
$24
Kiniksa Pharmaceuticals, Ltd.
$21
Radius Health, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$19
Teva Pharmaceuticals USA, Inc.
$17
Mylan Institutional Inc.
$17
Fresenius Kabi USA, LLC
$16
Oxford Immunotec USA Inc
$13
Top 3 companies account for 42.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · EVUSHELD · Enbrel · GLOPERBA · HUMIRA · HYRIMOZ · Hulio · IDACIO · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · Leqembi · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · RAYOS · REMICADE · RENFLEXIS · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · Superion · T-SPOT.TB8 · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Lawrenceville?
Compare rheumatologists in the Lawrenceville area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
58
Per 100K population
6.0
County median income
$84,823
Nearest hospital
SUMMITRIDGE CENTER- PSYCHIATRY & ADDICTIVE MED
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ban is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ban experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ban performed 180 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ban receive payments from pharmaceutical companies?
Yes. Dr. Ban received a total of $14,522 from 35 companies across 761 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ban's costs compare to other rheumatologists in Lawrenceville?
Dr. Ban's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ban) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →